Adv Mind Body Med. 2021;35(4):24-28.
Obesity is associated with chronic diseases, including metabolic syndrome and cardiovascular diseases (CVDs). Fasting is commonly employed by obese people to reduce their weight. Likewise, yoga and naturopathy (YN) that include liquid fasting (LF) have been shown to be beneficial in reducing weight for people with metabolic disorders. However, the safety of LF during YN treatments and its effects on metabolic and cardiovascular risk factors haven't yet been reported.
The study intended to evaluate the safety of LF during YN treatments and its effects on metabolic and cardiovascular risk factors in people with obesity.
A single-group, pretest-and-posttest design was adopted for the study.
The study took place in a YN hospital located in South India.
Participants were 176 obese people aged between 18 and 65 years.
Together with YN treatments, all participants underwent LF using lime juice with jaggery, ash guard juice, vegetable soup, buttermilk, and kokum juice for a period of 5 consecutive days.
Assessments such as body weight, body mass index (BMI), fat mass, lipid profile, and blood pressure were taken at baseline and postintervention.
Participants showed a significant reduction in body weight, BMI, fat mass, triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), very-low-density lipoprotein cholesterol (VLDL-C), high-density lipoprotein cholesterol (HDL-C), systolic blood pressure (SBP), and diastolic blood pressure (DBP).
The results suggest that LF during YN treatment canbe effective in reducing metabolic and cardiovascular risk factors in people with obesity.
肥胖与慢性疾病有关，包括代谢综合征和心血管疾病（CVD）。禁食是肥胖者常用的减肥方法。同样，瑜伽和顺势疗法（YN），包括液体禁食（LF），已被证明对代谢紊乱患者减轻体重有益。然而，YN 治疗期间 LF 的安全性及其对代谢和心血管危险因素的影响尚未报道。
本研究旨在评估 YN 治疗期间 LF 的安全性及其对肥胖患者代谢和心血管危险因素的影响。
本研究采用单组、前后测试设计。
研究在印度南部的一家 YN 医院进行。
参与者为 176 名年龄在 18 岁至 65 岁之间的肥胖者。
所有参与者在接受 YN 治疗的同时，连续 5 天饮用石灰汁加糖蜜、灰树花汁、蔬菜汤、白脱牛奶和可可姆果汁进行 LF。
在基线和干预后进行体重、体重指数（BMI）、体脂肪量、血脂谱和血压评估。
参与者的体重、BMI、体脂肪量、三酸甘油脂（TG）、总胆固醇（TC）、低密度脂蛋白胆固醇（LDL-C）、极低密度脂蛋白胆固醇（VLDL-C）、高密度脂蛋白胆固醇（HDL-C）、收缩压（SBP）和舒张压（DBP）均显著降低。
结果表明，YN 治疗期间的 LF 可能有效降低肥胖患者的代谢和心血管危险因素。
